Short term results of minimally invasive outpatient local anaesthetic administration of botulinum toxin-A for neurogenic detrusor overactivity (NDO).

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF ENDOUROLOGY | 2004年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A106 / A106
页数：1
相关论文
共 50 条
  • [21] Definition of botulinum toxin failure in neurogenic detrusor overactivity: Preliminary results of the DETOX survey
    Peyronnet, B.
    Sanson, S.
    Annarenco, G.
    Castel-Lacanal, E.
    Chartier-Kastler, E.
    Charvier, K.
    Damphousse, M.
    Denys, P.
    de Seze, M.
    Egon, G.
    Even, A.
    Forin, V.
    Karsenty, G.
    Kerdraon, J.
    le Normand, L.
    Loche, C. -M.
    Manunta, A.
    Mouracade, P.
    Phe, V.
    Previnaire, J. -G.
    Ruffion, A.
    Saussine, C.
    Schurch, B.
    Game, X.
    PROGRES EN UROLOGIE, 2015, 25 (17): : 1219 - 1224
  • [22] Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity
    Peyronnet, Benoit
    Roumiguie, Mathieu
    Castel-Lacanal, Evelyne
    Guillotreau, Julien
    Malavaud, Bernard
    Marque, Philippe
    Rischmann, Pascal
    Game, Xavier
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 (02) : 267 - 270
  • [23] Patients' perspective of the efficacy of intradetrusor botulinum toxin-A injections for treatment of neurogenic detrusor overactivity secondary to spinal cord injury
    Hori, S.
    Patki, P.
    Attar, K. H.
    Ismail, S.
    Shah, P. J. R.
    BJU INTERNATIONAL, 2008, 101 : 25 - 25
  • [24] A cost consequence model for botulinum toxin-A used in the treatment of 89 patients with detrusor overactivity: Preliminary results
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 104 - 104
  • [25] Can videourodynamics predict the success of first and repeat multifocal botulinum toxin a (BTX-A) injections in severe neurogenic detrusor overactivity (NDO)?
    Grosse, JO
    Kramer, GA
    Stöhrer, M
    JOURNAL OF UROLOGY, 2004, 171 (04): : 449 - 449
  • [26] BOTULINUM TOXIN A IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY: PRELIMINARY RESULTS FROM A CANADIAN MULTICENTRE RANDOMIZED TRIAL
    Herschorn, Sender
    Gajewski, Jerzy
    Ethans, Karen
    Corcos, Jacques
    Carlson, Kevin
    Bailly, Greg
    Rob, Bard
    Luc, Valiquette
    Richard, Baverstock
    Sidney, Radomski
    NEUROUROLOGY AND URODYNAMICS, 2009, 28 (02) : 138 - 139
  • [27] Long-term discontinuations of botulinum toxin a intradetrusor injections for neurogenic detrusor overactivity: a multicenter study
    Peyronnet, Benoit
    Baron, Maximilien
    Auble, Annabelle
    Hascoet, Juliette
    Castel-Lacanal, Evelyne
    Miget, Gabriel
    Prudhomme, Thomas
    Manunta, Andrea
    Cornu, Jean-Nicolas
    Game, Xavier
    NEUROUROLOGY AND URODYNAMICS, 2019, 38 : S82 - S83
  • [28] Long-Term Discontinuation of Botulinum Toxin A Intradetrusor Injections for Neurogenic Detrusor Overactivity: A Multicenter Study
    Baron, Maximilien
    Peyronnet, Benoit
    Auble, Annabelle
    Hascoet, Juliette
    Castel-Lacanal, Evelyne
    Miget, Gabriel
    Le Doze, Sabine
    Prudhomme, Thomas
    Manunta, Andrea
    Cornu, Jean-Nicolas
    Game, Xavier
    JOURNAL OF UROLOGY, 2019, 201 (04): : 769 - 776
  • [29] Botulinum Toxin-A can be used to manage neurogenic detrusor overactivity in adults with Spina Bifida but is less effective in the management of poor compliance
    Dowling, C.
    Whishaw, M.
    Elmer, S.
    Ong, T. J.
    BJU INTERNATIONAL, 2018, 121 : 9 - 9
  • [30] INTRAVESICAL ELECTROMOTIVE BOTULINUM TOXIN TYPE A ADMINISTRATION: PRELIMINARY FINDINGS FOR THE TREATMENT OF CHILDREN WITH MYELOMENINGOCELE AND REFRACTORY NEUROGENIC DETRUSOR OVERACTIVITY
    Ahmadi, Hamed
    Montaser-Kouhsari, Laleh
    Kajbafzadeh, Abdol-Mohammad
    JOURNAL OF UROLOGY, 2010, 183 (04): : E291 - E291
12345